London Stock Exchange today welcomes Intuitive Investments Group plc (‘Intuitive’, the ‘Company’ or ‘Group’), an investing company focussed on gaining exposure to Life Sciences businesses, to celebrate the listing of the Company's public shares onto AIM, under the ticker "IIG".

The Company is a newly established investing company, seeking to provide investors in the Company with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board’s experience and in particular that of the Chairman, David Evans, to seek to generate capital growth over the long term for shareholders.

Strand Hanson Limited is acting as Nominated Adviser and Turner Pope Investments (TPI) Ltd is acting as Broker and Sole Bookrunner.

•    Intuitive Investments Group plc raised £7.85m gross with net proceeds being used to:
–    to invest in fast growing and / or high potential life sciences businesses, based predominantly in the UK, wider Europe and the US, chosen from an identified pipeline of investment opportunities
–    investments will be focused on diagnostics and healthcare, medical devices, tools and technologies and bio-therapeutics and pharmaceuticals

From February 2021 Rob Naylor will work alongside David and the team as Chief Executive Officer. Rob Naylor has 24 years’ experience in capital markets; most recently at Cenkos Securities plc as head of corporate finance and corporate broking in the investment funds team. Robert has advised a number of Life Science companies and has worked closely with David over many years.

David Evans, Chairman of Intuitive Investments Group plc, said: “We are really pleased to be joining AIM today. With our combined experience and demonstrative track record in the sector we look to the future and invest in fast growing and / or high potential life sciences businesses, based predominantly in the UK, wider Europe and the US, chosen from an identified pipeline of investment opportunities.

“We will look for investments focused on diagnostics and healthcare, medical devices, tools and technologies and bio-therapeutics and pharmaceuticals.”

To find out more about Intuitive Investments Group plc visit: www.iigplc.com